OAK BROOK, Ill.--(BUSINESS WIRE)--INVIRION Diagnostics, LLC, successfully launched their new Molecular Hybrid Platform (MoHP) at EUROGIN 2008 (European Research Organization on Genital Infection and Neoplasia). EUROGIN is the leading international multidisciplinary organization involved in research, training, screening, prevention and information concerning genital infections, pre-cancers and cancers in women. INVIRION’S Hybrid Platform is a revolutionary instrument that allows clinicians to perform solution based and cell based molecular diagnostics on one simple yet robust platform. Following the launch, INVIRION Diagnostics will install its first unit in a hospital in Vietnam this week as part of its population based solution to Vietnam’s high prevalence of cervical cancer.
